Company / Operating Margin
Tvardi Therapeutics, Inc. Operating Margin History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-209.1%
FY2024
5-year range
-574.5% / 4.0%
FY2020-FY2024
Trend
+46.0%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin has fluctuated over the past 10 years, ranging from -67907.0% in FY2018 to 4.0% in FY2022.
Based on SEC 10-K filings.
-209.1% in FY2024 with a 5-year CAGR of +6320.6%.
Declined from 4.0% to -209.1% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- +352.5pp
- 5-Year Change
- +6320.6pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, operating margin increased 46.0% year-over-year.
- Peak operating margin was recorded in FY2022.
- Lowest operating margin in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -6.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -209.1% | +46.0% |
| FY2023 | -386.9% | -9795.5% |
| FY2022 | 4.0% | +100.7% |
| FY2021 | -561.6% | +2.2% |
| FY2020 | -574.5% | +91.2% |
| FY2019 | -6529.6% | +90.4% |
| FY2018 | -67907.0% | -10152.9% |
| FY2017 | -662.3% | -16.4% |
| FY2016 | -568.8% | -28629.3% |
| FY2015 | -2.0% | +99.6% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026